Sign In
Last checked at 
2 Mar 2026 15:30
EKF Diagnostics Holdings plc
("EKF" or the "Company")
Total Voting Rights
EKF Diagnostics Holdings plc (AIM: EKF), the?AIM-listed global diagnostics business, in accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, announces that the total issued share capital of the Company consists of 431,963,112 ordinary shares of 1p each in the capital of the Company ("Ordinary Shares"), of which 141,000 Ordinary Shares are held in treasury. Therefore, the total number of Ordinary Shares carrying voting rights will be 431,822,112.
The above figure of 431,822,122 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
EKF Diagnostics Holdings plc | www.ekfdiagnostics.com | ||
Julian Baines, Executive Chair Gavin Jones, Chief Executive Officer | via Walbrook PR | ||
Singer Capital Markets (Nominated Adviser & Broker) | Tel: +44 (0)20 7496 3000 | ||
Phil Davies / Patrick Weaver | |||
Walbrook PR Limited | Tel: +44 (0)20 7933 8780 or ekf@walbrookpr.com | ||
Paul McManus / Alice Woodings | Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654 | ||
About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)
EKF is an AIM-listed global diagnostics business focussed on:
? | Point-of-Care analysers in the key areas of Hematology and Diabetes |
? | Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. |
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
Follow the stocks
